Global Immunosuppressants API Market By Method (Synthetic Chemistry, Peptide chemistry, Fermentation, Chromatographic purification), By Application, By Type, By Product, By APIs, By End User, By Region, Competition, Forecast & Opportunities, 2025

The Global Immunosuppressants API Market is expected to grow at a formidable rate during the forecast period predominantly on account of continuous technological advancements in tissue engineering. Moreover, surging incidence of autoimmune disorders such as multiple sclerosis, alopecia areata and arthritis is positively impacting the growth of the market. Also, increase in organ transplants such as liver & kidney transplants worldwide are further expected to bolster the growth of the market over the next few years. However, certain factors that can act as major impediments to the growth of the Global Immunosuppressants API Market in the forthcoming years include high costs associated with API and lack of availability of organ donors.

The Global Immunosuppressants API Market is segmented based on method, application, type, product, APIs, end-user, and region. Based on product, the market can be categorized into tablets, capsules, liquids and injections; out of which, the tablet segment dominated the market and is expected to maintain its leading position during the forecast period as well, majorly on account of their longer shelf life coupled with cost-effective manufacturing process. Additionally, they can accommodate a higher dose of active ingredient as compared to capsules, which is further expected to boost the segmental growth over the coming years. In terms of application, the market is fragmented into autoimmune disease and organ transplant. The autoimmune disease segment held the largest market share until 2019 and is forecast to register higher growth during the forecast period, which is attributable to growing prevalence of autoimmune diseases across the globe. Based on end-user, the market is categorized into biotechnology & biopharmaceutical companies, CMOs, CROs, CDMOs, and Others. Among them, the biotechnology & biopharmaceutical companies segment is projected to dominate the market over the next five years, on account of rising investments for research and developmental activities.

Major players operating in the Global Immunosuppressants API Market include Biocon Ltd., NATCO Pharma Limited, Triveni Interchem Private Limited, Concord Biotech Ltd., RPG Life Sciences Limited, Jiangsu Jiuyang Bio-Pharmaceutical Co. Ltd, Chunghwa Chemical Synthesis & Biotech Co. Ltd., AbbVie Inc., Pfizer Inc., Zhejiang Hisun Pharmaceutical Co. Ltd. among others. Leading market players are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, collaborations, partnership, and agreements to increase customer base and expand geographic reach.

Years considered for this report:

Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025

Objective of the Study:

To analyze and estimate the market size of the Global Immunosuppressants API Market from 2015 to 2018.
To estimate and forecast the market size of the Global Immunosuppressants API Market from 2019 to 2025.
To classify and forecast the Global Immunosuppressants API Market based on method, application, type, product, APIs, end-user, and regional distribution.
To identify dominant region or segment in the Global Immunosuppressants API Market.
To identify drivers and challenges for the Global Immunosuppressants API Market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Immunosuppressants API Market.
To conduct pricing analysis for the Global Immunosuppressants API Market.
To identify and analyze the profile of leading players operating in the Global Immunosuppressants API Market.
to identify key sustainable strategies adopted by market players in the Global Immunosuppressants API Market.

The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of companies across the globe. Subsequently, researchers conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the companies which could not be identified due to the limitations of secondary research. The author analyzed the companies and presence of all major players operating across the globe.

The author calculated the market size of the Global Immunosuppressants API Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. Researchers sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:

Immunosuppressants API companies
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to immunosuppressants API
Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, suppliers and partners, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global Immunosuppressants API Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

By Method:
Synthetic Chemistry
Peptide chemistry
Fermentation
Chromatographic purification
By Application:
Autoimmune Disease
Organ Transplant
By Type:
Corticosteroids
Janus kinase inhibitor
Calcineurin inhibitors
mTOR inhibitor
IMDH inhibitor
Biologics
Monoclonal antibodies
By Product:
Tablets
Capsules
Liquids
Injections
By APIs:
Tacrolimus
Sirolimus
Everolimus
Mycophenolate Mofetil
Mycophenolate Sodium
By End-User:
Biotechnology & Biopharmaceutical Companies
CMOs
CROs
CDMOs
Others
By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Asia-Pacific
China
Japan
India
South Korea
Australia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
South America
Brazil
Argentina
Colombia

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Immunosuppressants API Market.

Available Customizations:
With the given market data, researchers offers customizations according to a company’s specific needs.

1. Product Overview2. Research Methodology3. Impact of COVID-19 on Global Immunosuppressants API Market4. Executive Summary5. Voice of Customer

6. Global Immunosuppressants API Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Method (Synthetic Chemistry, Peptide chemistry, Fermentation, Chromatographic purification)
6.2.2. By Application (Autoimmune Disease, Organ Transplant)
6.2.3. By Type (Corticosteroids, Janus kinase inhibitor, Calcineurin inhibitors, mTOR inhibitor, IMDH inhibitor, Biologics, Monoclonal antibodies)
6.2.4. By Product (Tablets, Capsules, Liquids, Injections)
6.2.5. By APIs (Tacrolimus, Sirolimus, Everolimus, Mycophenolate Mofetil (MMF), Mycophenolate Sodium (MPA))
6.2.6. By End User (Biotechnology & Biopharmaceutical Companies, CMOs, CROs, CDMOs, Others)
6.2.7. By Company (2019)
6.2.8. By Region
6.3. Product Market Map

7. Asia-Pacific Immunosuppressants API Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Method
7.2.2. By Application
7.2.3. By Type
7.2.4. By Product
7.2.5. By APIs
7.2.6. By End User
7.2.7. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Immunosuppressants API Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Method
7.3.1.2.2. By Application
7.3.1.2.3. By Type
7.3.1.2.4. By Product
7.3.1.2.5. By APIs
7.3.1.2.6. By End User
7.3.2. India Immunosuppressants API Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Method
7.3.2.2.2. By Application
7.3.2.2.3. By Type
7.3.2.2.4. By Product
7.3.2.2.5. By APIs
7.3.2.2.6. By End User
7.3.3. Australia Immunosuppressants API Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Method
7.3.3.2.2. By Application
7.3.3.2.3. By Type
7.3.3.2.4. By Product
7.3.3.2.5. By APIs
7.3.3.2.6. By End User
7.3.4. Japan Immunosuppressants API Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Method
7.3.4.2.2. By Application
7.3.4.2.3. By Type
7.3.4.2.4. By Product
7.3.4.2.5. By APIs
7.3.4.2.6. By End User
7.3.5. South Korea Immunosuppressants API Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Method
7.3.5.2.2. By Application
7.3.5.2.3. By Type
7.3.5.2.4. By Product
7.3.5.2.5. By APIs
7.3.5.2.6. By End User

8. Europe Immunosuppressants API Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Method
8.2.2. By Application
8.2.3. By Type
8.2.4. By Product
8.2.5. By APIs
8.2.6. By End User
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. France Immunosuppressants API Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Method
8.3.1.2.2. By Application
8.3.1.2.3. By Type
8.3.1.2.4. By Product
8.3.1.2.5. By APIs
8.3.1.2.6. By End User
8.3.2. Germany Immunosuppressants API Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Method
8.3.2.2.2. By Application
8.3.2.2.3. By Type
8.3.2.2.4. By Product
8.3.2.2.5. By APIs
8.3.2.2.6. By End User
8.3.3. United Kingdom Immunosuppressants API Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Method
8.3.3.2.2. By Application
8.3.3.2.3. By Type
8.3.3.2.4. By Product
8.3.3.2.5. By APIs
8.3.3.2.6. By End User
8.3.4. Italy Immunosuppressants API Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Method
8.3.4.2.2. By Application
8.3.4.2.3. By Type
8.3.4.2.4. By Product
8.3.4.2.5. By APIs
8.3.4.2.6. By End User
8.3.5. Spain Immunosuppressants API Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Method
8.3.5.2.2. By Application
8.3.5.2.3. By Type
8.3.5.2.4. By Product
8.3.5.2.5. By APIs
8.3.5.2.6. By End User

9. North America Immunosuppressants API Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Method
9.2.2. By Application
9.2.3. By Type
9.2.4. By Product
9.2.5. By APIs
9.2.6. By End User
9.2.7. By Country
9.3. North America: Country Analysis
9.3.1. United States Immunosuppressants API Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Method
9.3.1.2.2. By Application
9.3.1.2.3. By Type
9.3.1.2.4. By Product
9.3.1.2.5. By APIs
9.3.1.2.6. By End User
9.3.2. Mexico Immunosuppressants API Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Method
9.3.2.2.2. By Application
9.3.2.2.3. By Type
9.3.2.2.4. By Product
9.3.2.2.5. By APIs
9.3.2.2.6. By End User
9.3.3. Canada Immunosuppressants API Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Method
9.3.3.2.2. By Application
9.3.3.2.3. By Type
9.3.3.2.4. By Product
9.3.3.2.5. By APIs
9.3.3.2.6. By End User

10. South America Immunosuppressants API Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Method
10.2.2. By Application
10.2.3. By Type
10.2.4. By Product
10.2.5. By APIs
10.2.6. By End User
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Immunosuppressants API Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Method
10.3.1.2.2. By Application
10.3.1.2.3. By Type
10.3.1.2.4. By Product
10.3.1.2.5. By APIs
10.3.1.2.6. By End User
10.3.2. Argentina Immunosuppressants API Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Method
10.3.2.2.2. By Application
10.3.2.2.3. By Type
10.3.2.2.4. By Product
10.3.2.2.5. By APIs
10.3.2.2.6. By End User
10.3.3. Colombia Immunosuppressants API Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Method
10.3.3.2.2. By Application
10.3.3.2.3. By Type
10.3.3.2.4. By Product
10.3.3.2.5. By APIs
10.3.3.2.6. By End User

11. Middle East and Africa Immunosuppressants API Market Outlook

11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product Type
11.2.2. By Source
11.2.3. By Method
11.2.4. By Technology
11.2.5. By Application
11.2.6. By End User
11.2.7. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Immunosuppressants API Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Method
11.3.1.2.2. By Application
11.3.1.2.3. By Type
11.3.1.2.4. By Product
11.3.1.2.5. By APIs
11.3.1.2.6. By End User
11.3.2. Saudi Arabia Immunosuppressants API Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Method
11.3.2.2.2. By Application
11.3.2.2.3. By Type
11.3.2.2.4. By Product
11.3.2.2.5. By APIs
11.3.2.2.6. By End User
11.3.3. UAE Immunosuppressants API Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Method
11.3.3.2.2. By Application
11.3.3.2.3. By Type
11.3.3.2.4. By Product
11.3.3.2.5. By APIs
11.3.3.2.6. By End User
11.3.4. Kuwait Immunosuppressants API Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Method
11.3.4.2.2. By Application
11.3.4.2.3. By Type
11.3.4.2.4. By Product
11.3.4.2.5. By APIs
11.3.4.2.6. By End User

12. Market Dynamics

12.1. Drivers
12.2. Challenges

13. Market Trends & Developments14. Patent Analysis

15. Competitive Landscape

15.1. Competition Outlook
15.2. Players Profiled (Leading Companies)
15.2.1. Biocon Ltd.
15.2.2. NATCO Pharma Limited
15.2.3. Triveni Interchem Private Limited
15.2.4. Concord Biotech Ltd.
15.2.5. RPG Life Sciences Limited
15.2.6. Jiangsu Jiuyang Bio-Pharmaceutical Co. Ltd
15.2.7. Chunghwa Chemical Synthesis & Biotech Co. Ltd.
15.2.8. AbbVie Inc.
15.2.9. Pfizer Inc.
15.2.10. Zhejiang Hisun Pharmaceutical Co Ltd

16. Strategic Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

Biocon Ltd.
NATCO Pharma Limited
Triveni Interchem Private Limited
Concord Biotech Ltd.
RPG Life Sciences Limited
Jiangsu Jiuyang Bio-Pharmaceutical Co. Ltd
Chunghwa Chemical Synthesis & Biotech Co. Ltd.
AbbVie Inc.
Pfizer Inc.
Zhejiang Hisun Pharmaceutical Co Ltd

Table of Contents

Companies Mentioned

Related Topics

Related Reports

Immunosuppressants API Market 2022-2028

Immunosuppressant Drugs Market Size Outlook to 2028 - Growth Opportunities, Immunosuppressant Drugs Market Insights, Companies, Market share by Types, Applications, and Countries

Organ Transplant Immunosuppressant Drugs Market Size Outlook to 2028 - Growth Opportunities, Organ Transplant Immunosuppressant Drugs Market Insights, Companies, Market share by Types, Applications, and Countries

Immunosuppressant Drugs Market Research Report by Function (Autoimmune Diseases and Organ Transplant), Drug Class, Route of Administration, End User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

Organ Transplant Immunosuppressant Drugs Market Research Report by Drug Class, Transplant Type, Distribution Channel, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030